MANEVSMRNA• 28 Days (Normalized)
MANE vs MRNA (Veradermics Incorporated vs Moderna Inc.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
MANE Performance $116.76
+12.45%
Veradermics Incorporated
Normalized Baseline0.00%
MRNA Performance $190.01
+35.4%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-22.95 pts
MRNA outperforming by 22.95 percentage points
MANEMRNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
MANE MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | MANE Price | MANE Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $116.76 | +12.45% | $190.01 | +35.40% | -22.95% |
| Oct 01, 2026 | $- | $188.94 | +34.64% | - | |
| Sep 30, 2026 | $- | $192.57 | +37.23% | - | |
| Sep 29, 2026 | $- | $203.46 | +44.99% | - | |
| Sep 28, 2026 | $- | $197.28 | +40.58% | - | |
| Sep 25, 2026 | $- | $198.88 | +41.72% | - | |
| Sep 24, 2026 | $115.72 | +11.45% | $- | - | |
| Sep 23, 2026 | $115.78 | +11.51% | $182.11 | +29.77% | -18.26% |
| Sep 22, 2026 | $118.14 | +13.78% | $182.56 | +30.09% | -16.31% |
| Sep 21, 2026 | $112.80 | +8.64% | $172.94 | +23.24% | -14.60% |
| Sep 18, 2026 | $106.75 | +2.81% | $154.04 | +9.77% | -6.96% |
| Sep 17, 2026 | $108.68 | +4.67% | $158.07 | +12.64% | -7.97% |
| Sep 16, 2026 | $102.42 | -1.36% | $145.62 | +3.77% | -5.13% |
| Sep 15, 2026 | $103.89 | +0.06% | $143.77 | +2.45% | -2.39% |
| Sep 14, 2026 | $101.70 | -2.05% | $146.69 | +4.53% | -6.58% |
Page 1 of 2